Related Experiment Video
Updated: Aug 31, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Moyamoya-induced paroxysmal dyskinesia
Pedro Gonzalez-Alegre1, Zakaria Ammache, Patricia H Davis
1Department of Neurology, University of Iowa College of Medicine, Iowa City, Iowa 52242, USA.
Abstract:
Moyamoya disease (MMD) is an uncommon intracranial vasculopathy that typically presents with ischemic or hemorrhagic stroke. Persistent choreoathetosis has been identified as a rare early manifestation of MMD. We present 2 patients with paroxysmal dyskinesia as the initial symptom of MMD, one resembling paroxysmal kinesigenic dyskinesia (PKD) and the other paroxysmal non-kinesigenic dyskinesia (PNKD). We also review the cases of moyamoya-induced chorea reported previously, none of which resembled PKD or PNKD. We hypothesize that both hormonal and ischemic factors may be implicated in the pathogenesis of these abnormal involuntary movements. These cases suggest that MMD should be included in the differential diagnosis of PKD and PNKD.
Insights
Moyamoya disease (MMD) can initially present as rare movement disorders, specifically paroxysmal dyskinesias. This suggests MMD should be considered in the differential diagnosis for these conditions.
Area of Science:
- Neurology
- Vascular Neurology
- Movement Disorders
Background:
- Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive stenosis of intracranial arteries.
- While typically presenting with stroke, MMD can manifest with other neurological symptoms.
Observation:
- This study reports two cases where paroxysmal dyskinesia, resembling paroxysmal kinesigenic dyskinesia (PKD) and paroxysmal non-kinesigenic dyskinesia (PNKD), was the initial symptom of MMD.
- A review of prior literature found no reported cases of moyamoya-induced chorea mimicking PKD or PNKD.
Findings:
- The presented cases highlight that MMD can manifest with specific types of paroxysmal dyskinesia as an early, presenting symptom.
- These involuntary movements may be linked to both hormonal influences and ischemic factors in MMD pathogenesis.
Implications:
- The findings suggest that MMD should be included in the differential diagnosis for patients presenting with paroxysmal kinesigenic dyskinesia and paroxysmal non-kinesigenic dyskinesia.
- This broadens the clinical recognition of MMD beyond typical stroke presentations, potentially leading to earlier diagnosis and intervention.
More Related Videos
07:35Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Alterations in Muscle Tone ll
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Dysrhythmias IV: Characteristics of Bradyarrhythmias